Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/15/2008
 
First Published:
11/10/2005
1.
Phase III Randomized Study of Two Different Schedules of Docetaxel in Combination With Prednisone in Patients With Hormone-Refractory Metastatic Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Over 18
Other
AVENTIS-FIN-1-2003
FINNISH-URO-OGS-1-2003, PROSTY-FIN-1-2003, NCT00255606
Last Modified:
7/11/2007
 
First Published:
5/23/2007
2.
Phase III Randomized Study of Recombinant Epoetin Alfa or Epoetin Beta With Versus Without Parenteral Iron in Anemic, Iron-Replete Patients With Nonmyeloid Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
Over 16
Other
BARTS-06/Q0605/93
ISRCTN11830961, EU-20731, 06/Q0605/93, NCT00482716
3.
SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
2007-000972-18
NCT00495547
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute